Prometheus Biosciences, Inc. - Common Stock (NQ:RXDX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 15, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prometheus Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Analyst Expectations for Prometheus Biosciences's Future ↗

March 01, 2023

Via Benzinga

Prometheus Biosciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Progress

February 28, 2023

From Prometheus Biosciences

Via GlobeNewswire

Prometheus Biosciences Announces Two Oral Presentations on PRA023 at the 18th Congress of European Crohn’s and Colitis Organisation (ECCO)

February 22, 2023

From Prometheus Biosciences

Via GlobeNewswire

Prometheus Biosciences to Present at the SVB Securities Global Biopharma Conference

February 09, 2023

From Prometheus Biosciences

Via GlobeNewswire

Analyst Expectations for Prometheus Biosciences's Future ↗

January 31, 2023

Via Benzinga

Looking Into Prometheus Biosciences's Return On Capital Employed ↗

December 16, 2022

Via Benzinga

Where Prometheus Biosciences Stands With Analysts ↗

December 08, 2022

Via Benzinga

How Is The Market Feeling About Prometheus Biosciences? ↗

January 04, 2023

Prometheus Biosciences's (NASDAQ:RXDX) short percent of float has fallen 35.76% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 8.3% of all...

Via Benzinga

Prometheus Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Prometheus Biosciences

Via GlobeNewswire

Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022 ↗

December 31, 2022

2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 23, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector ↗

December 23, 2022

The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Why Prometheus Biosciences Stock Is Falling ↗

December 09, 2022

Prometheus Biosciences Inc (NASDAQ: RXDX) shares are trading lower by 6.01% to $110.16 going into the close of Friday's session after the company priced a public upsized $500 million offering.

Via Benzinga

Is Prometheus Biosciences a Good Stock to Buy Right Now? ↗

December 09, 2022

This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead.

Via The Motley Fool

Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common Stock

December 08, 2022

From Prometheus Biosciences

Via GlobeNewswire

Why Prometheus Biosciences Stock Is Rocketing Higher Today ↗

December 08, 2022

Prometheus Biosciences Inc (NASDAQ: RXDX) shares are trading higher Thursday after multiple analyst firms raised price targets on the stock following positive results from the company's PRA023 in both

Via Benzinga

Analyzing Prometheus Biosciences's Short Interest ↗

December 08, 2022

Prometheus Biosciences's (NASDAQ:RXDX) short percent of float has risen 5.39% since its last report. The company recently reported that it has 4.89 million shares sold short, which is 13.3% of all...

Via Benzinga

Why Shares of Prometheus Biosciences Are Soaring This Week ↗

December 08, 2022

The clinical-stage biotech that specializes in IBD therapies announced positive news regarding two trials for its lead therapy.

Via The Motley Fool

Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday ↗

December 08, 2022

Via Benzinga

Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

December 07, 2022

U.S. markets continued their weak trend on Wednesday, with next week’s Federal Open Market Committee meeting beginning to weigh on investors’ minds.

Via Benzinga

Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028

December 08, 2022

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NYSE:BMY),(NASDAQ:RXDS),(NASDAQ:RNAZ) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common Stock

December 07, 2022

From Prometheus Biosciences

Via GlobeNewswire

Dow Edges Higher; Prometheus Biosciences Shares Jump ↗

December 07, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday.

Via Benzinga

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗

December 07, 2022

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 07, 2022

Via Benzinga

Prometheus Biosciences (NASDAQ: RXDX) Reports PRA023 Candidate Achieved Positive Results in Both its ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Clinical Trials

December 07, 2022

Prometheus Biosciences, Inc. (NASDAQ: RXDX) is engaged as a clinical-stage biotechnology company, which is focused on the research, development and

Via Spotlight Growth

Nasdaq Drops 75 Points; Crude Oil Down 2% ↗

December 07, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday.

Via Benzinga

Dow Bounces Back From Morning Selloff ↗

December 07, 2022

The Dow Jones Industrial Average is trying to claw back from the market's multi-day selloff. Meanwhile, the S&P 500 Index and Nasdaq Composite Index continue to flag near breakeven.

Via Talk Markets

PINS Stock Alert: What to Know as Pinterest and Elliott Strike a Deal ↗

December 07, 2022

Pinterest (PINS) stock is on the move Wednesday as investors react to an agreement with Elliott Investment Management L.P.

Via InvestorPlace

US Stocks Mixed; Dow Rises 50 points ↗

December 07, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining more than 50 points on Wednesday.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.